Red-Hair Gene Offers New Path for Chronic Wound Healing
Summary: A groundbreaking PNAS study reveals that the melanocortin-1 receptor (MC1R) pathway — best known for red hair pigmentation — is critically impaired in chronic wounds like diabetic foot ulcers (DFUs), venous leg ulcers (VLUs), and pressure ulcers (PIs). The research, using human biopsies and mouse models, shows MC1R dysfunction disrupts the shift from inflammation to tissue repair, leading to prolonged immune cell presence and stalled healing. In mice with functional MC1R (‘black-fur’), topical MC1R agonist cream boosted vascularization, reduced inflammation, and achieved 93% wound closure at 7 days (vs 73% in ‘red-fur’ MC1R-deficient mice). Agonist therapy was ineffective without partial receptor function, suggesting targeted treatments for patients with at least some MC1R activity. This opens doors to novel topical gels/ointments resolving chronic inflammation, potentially transforming care for the 10M+ annual U.S. chronic wounds.
Key Highlights:
- MC1R Role: Expressed in immune cells, keratinocytes, fibroblasts, vascular cells; variants (red-hair linked) impair POMC-MC1R axis, causing persistent inflammation and poor repair.
- Human Evidence: Biopsies from chronic wounds show MC1R downregulation vs acute; correlates with stalled granulation.
- Mouse Model: Functional MC1R + agonist: 93% closure, ↑ vascularization, ↓ immune cells; deficient: only 73%, no agonist benefit.
- Implications: Topical MC1R activators for patients with partial function; could address 30-50% non-healing rate in DFUs.
- Future: Preclinical stage; human trials needed; “MC1R may play a more significant role in wound biology than previously understood” — authors.
Keywords: MC1R, red hair gene, chronic wound, DFU, inflammation resolution